References
- Linker‐Israeli M., Bokke A. C., Kitridou R. C., Gendler S. Defective production of interleukin 1 and inerleukin 2 in patients with systemic lupus erythematosus (SLE). J. Immunol 1983; 130: 2651–2655
- Huang Y. P., Perrin L. H., Miescher P. A., Zubler R. H. Correlation of T and B cell activities in vitro and serum IL‐2 levels in systemic lupus erythematosus. J. Immunol 1988; 141: 827–833
- Kroemer S., Wick G. The role of interleukin 2 in autoimmunity. Immunol. Today 1989; 10: 246–251
- Tsokos G. C. Lymphocyte abnormalities in human lupus. Clin. Immunol. Immunopathol 1992; 63: 7–9
- Huang Y. P., Miescher P. A., Zubler R. H. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. Immunol 1986; 137: 3515–4520
- Santoro J., Luger T. A., Ravache E. S., Steinberg A. D. In vitro correction of the interleukin 2 defect in autoimmune mice. Europ. J. Immunol 1983; 13: 601–604
- Theofilopoulos A. N., Prud'homme G. J., Dixon F. J., Dixon F. J. Autoimmune aspects of systemic lupus erythematosus. Concept. Immunopathol 1985; 1: 190–218
- Linker‐Israeli M. Cytokine abnormalities in human lupus. Clin. Immunol. Immunopathol 1992; 63: 10–12
- Tanaka Y., Saito K., Shirakawa I., Oto T., Suzuki H., Eto S. Production of B cell‐stimulating factors by B cells in patients with systemic lupus erythematosus. J. Immunol 1988; 141: 3043–3047
- Fagiolo E., Vigevani F., Pozzetto U. High cytokine serum levels in patients with autoimmune hemolytic anemia (AIHA). Immunol. Investig 1994; 23: 449–456
- Gutierrez‐Ramos J. C., Moreno De Alboran I., Martinez ‐A. C. In vivo administration of interleukine‐2 turns on anergic self‐reactive T cells and leads to autoimmune disease. Eur. J. Immunol 1992; 22: 2867–2872
- Heat W. R., Allison J., Hoffman M. W., Schonrich G., Hammerling G., Arnold B., Miller J. F. A. P. Autoimmune diabetes as a consequence of locally produced interleukin‐2. Nature 1992; 359: 547–548
- Gutierrez‐Ramos J. C., Andreu J. L., Revilla Y., Vinuela E., Martinez ‐A. C. Recovery from autoimmunity of MRL/lpr mice after infection with an interleukin‐2/vaccinia recombinant virus. Nature 1990; 346: 271–272
- Jacob C. O. Studies on the role of tumor necrosis factor in murine and human autoimmunity. J. Autoim 1992; 5(supplement A)133–143
- Feldmann M., Brennan F. M., Chantry D., Haworth C., Turner M., Katsikis P., Londei M., Abney E., Buchan G., Barrett K., Corcoran A., Kissonerghis M., Zheng R., Grubeck‐Loebenstein B., Barkley D., Chu C. Q., Field M., Maini R. N. Cytokine assays: role in evaluation of the pathogenesis of autoimmunity. Immunol. Rev 1991; 119: 105–123
- Harrison L. C. Cytokine mechanisms of beta cell destruction in insulin‐dependent diabetes mellitus. Interf Cytok 1992; 20: 9–12
- Sundblad A., Hauser S., Holmberg D., Cazenave P. ‐A., Coutinho A. Suppression of antibody response to the acetylcholine receptor by natural antibodies. Eur. J. Immunol 1989; 19: 1425–1430
- Bloom B. R., Salgame P., Diamond B. Revisiting and revising suppressor T cells. Immunol. Today 1992; 13: 131–136
- Elson C. J., Barker R. N., Thomspon S. J., Williams N. A. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol. Today 1995; 16: 71–80
- Gilbert K. M., Weigle W. O. Tolerogenicity of resting and activated B cells. J. Exp. Med 1994; 179: 249–258
- Miysaka N., Nakamura T., Russel I., Talal N. Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus. Clin. Immunol. Immunopathol 1984; 31: 109–117
- Miller R. D., Calkins C. E. Active role of T cells in promoting an in vitro autoantibody response to self erythrocytes in NZB mice. Immunol 1988; 63: 625–630
- Reininger L., Radaszkiewicz T., Kosco M., Melchers F., Rolink A. G. Development of autoimmune disease in SCID mice populated with long‐term “in vitro” proliferating (NZB/NZW) FI pre‐B cells. J. Exp. Med 1992; 176: 1343–1353
- Foxwell B. M. J., Barrett K., Feldmann M. Cytokine receptors: structure and signal transduction. Clin. Exp. Immunol 1992; 90: 161–169
- De Carli M., D'elios M. M., Zancuoghi G., Romagnani S., Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoim 1994; 18: 301–308
- Vilcek J., Lee T. H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem 1991; 266: 7313–7316
- Waldmann T. A. The IL‐2/IL‐2 receptor system: a target for rational immune intervention. Immunol. Today 1993; 14: 264–270